AI assistant
Applied Therapeutics, Inc. — Director's Dealing 2022
Nov 18, 2022
34263_dirs_2022-11-17_425bef65-b926-4bbc-9c51-3e704326fd91.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2022-11-15
Reporting Person: Ortega Steven A. (Principal Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-15 | Common Stock | A | 40000 | $0.00 | Acquired | 55404 | Direct |
Footnotes
F1: Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on November 15, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.